HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
Perfumes, Cosmetics & Other Toilet Preparations
Best Cosmetics Stocks 2026 →
HLN Stock Analysis: Buy, Sell, or Hold?
$9.09
-0.01 (-0.11%)
âŧ
5d:
-0.66%
30d:
-6.1%
90d:
-6.29%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (88%)
Quality Score
50/100
Position
SLIGHTLY LOW
30-Day Fair Range
$8.89 â $10.00
Position: SLIGHTLY LOW
Forward P/E & Valuation
15.0x
FAIR
vs 16.2x historical avg
Wall Street Target
$10.40
+14.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$8.61 / $9.36
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: HLN is fairly priced but lacks strong directional signals. At -2.5% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Get Alerted When HLN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$12.92
Based on 5.7% avg growth
INTRINSIC VALUE TODAY
$8.02
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HLN is currently trading at $9.09, which is considered slightly low relative to its 30-day fair value range of $8.89 to $10.00. The stock's valuation (Forward PE: 15.0) is in line with its historical norms (16.2). Remarkably, the market is currently pricing in an annual earnings decline of 2.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, HLN is in a strong downtrend. The price is approaching resistance at $9.36. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: HLN scores 61/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $10.40 (+14.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HLN is in a strong downtrend. The price is approaching resistance at $9.36. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: HLN scores 61/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $10.40 (+14.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$8.89 -
$10.00
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
88.1%
Trading Range & Key Levels
30-Day Trading Range
$8.89 -
$10.00
Current vs Trading Range
SLIGHTLY LOW
Support Level
$8.61
Resistance Level
$9.36
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (61/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($10.40)
- WARNING: Composite score 50/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
15.04
Wall Street Target
$10.40
(+14.4%)
Revenue Growth (YoY)
2.2%
Earnings Growth (YoY)
-4.5%
Profit Margin
14.5%
Valuation Discount vs History
-2.5% cheaper
PE vs Historical
15.0 vs 16.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.5%
(market-implied from PE analysis)
1-Year Target
$8.86
(-3%)
2-Year Target
$8.64
(-5%)
3-Year Target
$8.43
(-7%)
3-Yr Target (if PE normalizes)
(PE: 15â16)
$9.08
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 7.4%)
$14.88
(+64%)
Base:
(SPY PE: 15.0, Growth: 7.4%)
$11.26
(+24%)
Bear:
(PE: 12.8, Growth: 7.4%)
$9.57
(+5%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 18.57 | Current EPS (TTM): $0.49
Bull Case
$12.35
(+36%)
Analyst growth 23.4%, PE expands to 20.4
Base Case
$11.23
(+24%)
Market implied 23.4%, PE stable at 18.6
Bear Case
$6.19
(-32%)
Severe decline -20.0%, PE contracts to 15.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.0 to 16.2
Stabilization Target:
$9.79
(+7.7%)
PE Expansion Potential:
+7.7%
Share HLN Analysis
Share this live HLN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (HLN)
Bearish
1 Retail Mentions
Reddit / WSB Comments
1
Bearish
Last Tracked
Aug 29, 2026
Daily AI digest
AI Retail Discussion Summary:
Reddit & WallStreetBets discussions on HLN are bearish (sentiment score -0.83) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 3:58 AM ET
Data refreshes hourly during market hours. Next update: 4:58 AM
Data refreshes hourly during market hours. Next update: 4:58 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HLN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences IâĻ |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 41 HOLD |
|
AQST
Aquestive Therapeutics IâĻ |
STRONG BUY
9 analysts |
$9 | 60 BUY |
|
TEVA
Teva Pharma Industries LâĻ |
STRONG BUY
15 analysts |
$49 | 36 SELL |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 51 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive HLN Research Pages
